Phocas Financial Corp. Lannett CO Inc Transaction History

Phocas Financial Corp.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$4.9 - $7.12 $790,002 - $1.15 Million	-161,225 Closed	0 $0
Q2 2020 Aug 24, 2020	SELL	$6.43 - $9.86 $90,097 - $138,158	-14,012 Reduced 8.0%	161,225 $1.17 Million
Q1 2020 May 15, 2020	BUY	$6.36 - $10.05 $1.11 Million - $1.76 Million	175,237 New	175,237 $1.22 Million

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.